KOREAN
English

ROPHIBIO

Primary Menu

Skip to content

회사소개
기술소개
파이프라인
- 바이오의약품 신약파이프라인
- 바이오시밀러 후보물질
뉴스/공지사항
Menu

Home > > Investor Relations

Investor Relations

Number	Title	Author	Date	Views

1

Menu

Korea Office: 301, 194-41, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu,
Cheongju-si, Chungcheongbuk-do, Korea; T: +82-43-239-0080 | F: +82-303-0956-0080 | Email: info@rophibio.com

US Office: 615 S Frederick Ave, Suite 302B Gaithersburg, MD 20877; TEL : 301-309-1601